Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 67.45 USD -10.99% Market Closed
Market Cap: 26.5B USD

Intrinsic Value

The intrinsic value of one DXCM stock under the Base Case scenario is 55.17 USD. Compared to the current market price of 67.45 USD, Dexcom Inc is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DXCM Intrinsic Value
55.17 USD
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Dexcom Inc

What is Valuation History?
Compare DXCM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Dexcom’s dominant position in continuous glucose monitoring faces mounting pressure from Abbott’s Freestyle Libre, which offers lower-cost options and wider distribution, potentially diluting Dexcom’s market share and pricing power.

Bull Theses

Dexcom’s recognized best-in-class accuracy and brand loyalty in Type 1 diabetes management could preserve its premium pricing and reinforce market leadership despite competitive threats.

Show More Less
How do you feel about DXCM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Dexcom Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dexcom Inc

Current Assets 5B
Cash & Short-Term Investments 2.9B
Receivables 1.4B
Other Current Assets 742m
Non-Current Assets 2.3B
PP&E 1.5B
Intangibles 111.3m
Other Non-Current Assets 671.8m
Efficiency

Free Cash Flow Analysis
Dexcom Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Dexcom Inc

Revenue
4.3B USD
Cost of Revenue
-1.7B USD
Gross Profit
2.6B USD
Operating Expenses
-1.9B USD
Operating Income
687.2m USD
Other Expenses
-115.7m USD
Net Income
571.5m USD
Fundamental Scores

DXCM Profitability Score
Profitability Due Diligence

Dexcom Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Positive ROE
Exceptional Gross Margin
ROE is Increasing
59/100
Profitability
Score

Dexcom Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

DXCM Solvency Score
Solvency Due Diligence

Dexcom Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
81/100
Solvency
Score

Dexcom Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 105.4 USD with a low forecast of 85.07 USD and a high forecast of 126 USD.

Lowest
Price Target
85.07 USD
26% Upside
Average
Price Target
105.4 USD
56% Upside
Highest
Price Target
126 USD
87% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dexcom Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DXCM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DXCM Insider Trading
Buy and sell transactions by insiders

DXCM News

Other Videos
What is the Intrinsic Value of one DXCM stock?

The intrinsic value of one DXCM stock under the Base Case scenario is 55.17 USD.

Is DXCM stock undervalued or overvalued?

Compared to the current market price of 67.45 USD, Dexcom Inc is Overvalued by 18%.

Back to Top